Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean aprd00168 of aprd00168?
Displaying 1 drug
Solifenacin is a competitive muscarinic receptor antagonist indicated to treat an overactive bladder with urinary incontinence, urgency, and frequency. It has a long duration of action as it is usually taken once daily. Solifenacin was granted FDA approval on 19 November 2004.
Displaying 1 drug